Clinical trial

Delta-THC in Dementia

NCT01608217

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-06-01

PhasePHASE2

Study timeline

Study start (unknown)2012-06-01Date precision: month

Registry last updated2014-06-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Behavioural Disturbancesunresolved

Painunresolved

Dementiaunresolved

Alzheimer's Dementiaunresolved

Vascular Dementiaunresolved

Interventions

delta-9-tetrahydrocannabinol (delta-THC)DRUG

AcetaminophenDRUG · verified · RxNorm: acetaminophen

AcetaminophenDRUG · verified · RxNorm: acetaminophen

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Health Valley, Netherlandscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01608217 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.